Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy.
Babamohamadi M, Mohammadi N, Faryadi E, Haddadi M, Merati A, Ghobadinezhad F, Amirian R, Izadi Z, Hadjati J.
Babamohamadi M, et al. Among authors: hadjati j.
Cell Death Dis. 2024 Jan 8;15(1):17. doi: 10.1038/s41419-023-06391-x.
Cell Death Dis. 2024.
PMID: 38191571
Free PMC article.
Review.